5 Einträge gefunden

1. Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy⋆

   1. Denkert, C
   2. Untch, M
   3. Benz, S
   4. Schneeweiss, A
   5. Weber, K E
   6. Schmatloch, S
   7. Jackisch, C

   2021 - Forschungsinformationssystem des UKE
2. Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†

   1. von Minckwitz, G
   2. Loibl, S
   3. Untch, M
   4. Eidtmann, H
   5. Rezai, M
   6. Fasching, P A
   7. Tesch, H

   2014 - Forschungsinformationssystem des UKE
3. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis.

   1. Untch, M
   2. von Minckwitz, G
   3. Konecny, G E
   4. Conrad, U
   5. Fett, W
   6. Kurzeder, C
   7. Lück, H-J

   2011 - Forschungsinformationssystem des UKE
4. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery.

   1. Untch, M
   2. Fasching, P A
   3. Konecny, G E
   4. von Koch, F
   5. Conrad, U
   6. Fett, W
   7. Kurzeder, C

   2011 - Forschungsinformationssystem des UKE
5. Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

   1. Schwarz, Jörg
   2. Tiling, R
   3. Avril-Sassen, S
   4. Mahner, Sven
   5. Lebeau, Annette
   6. Weber, Christoph
   7. Schwaiger, M

   2010 - Forschungsinformationssystem des UKE